Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | December 20, 2022 01:31pm

Gainers

  • Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 112.5 million, which is 9232.0% of its average full-day volume over the last 100 days. The company's market cap stands at $30.0 million.
  • Verona Pharma (NASDAQ:VRNA) stock rose 33.39% to $18.0. Trading volume for this security as of 12:30 EST is 12.3 million, which is 4920.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion.
  • Surrozen (NASDAQ:SRZN) shares rose 18.72% to $0.57. As of 12:30 EST, this security is trading at a volume of 2.9 million shares, making up 916.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.0 million.
  • Revelation Biosciences (NASDAQ:REVBU) stock increased by 16.71% to $0.28.
  • Vapotherm (NYSE:VAPO) stock increased by 16.24% to $2.2. As of 12:30 EST, this security is trading at a volume of 807.7K shares, making up 139.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $58.6 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 15.57% to $1.33. The current volume of 92.1K shares is 2.1% of Avenue Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $6.3 million.

Losers

  • Scopus BioPharma (NASDAQ:SCPS) stock fell 59.6% to $0.07 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 95.7K shares, making up 10.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 million.
  • Magenta Therapeutics (NASDAQ:MGTA) stock decreased by 53.98% to $0.38. Magenta Therapeutics's stock is trading at a volume of 3.6 million shares as of 12:30 EST. This is 411.4% of its average full-day volume over the last 100 days. The company's market cap stands at $23.1 million.
  • BioVie (NASDAQ:BIVI) stock declined by 32.27% to $6.78. BioVie's stock is trading at a volume of 3.0 million shares as of 12:30 EST. This is 341.9% of its average full-day volume over the last 100 days. The company's market cap stands at $220.1 million.
  • Axcella Health (NASDAQ:AXLA) shares decreased by 31.63% to $0.29. Axcella Health's stock is trading at a volume of 2.2 million shares as of 12:30 EST. This is 325.1% of its average full-day volume over the last 100 days. The company's market cap stands at $21.6 million.
  • Arcus Biosciences (NYSE:RCUS) stock decreased by 27.9% to $22.0. As of 12:30 EST, Arcus Biosciences's stock is trading at a volume of 2.5 million, which is 288.8% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 billion.
  • Entrada Therapeutics (NASDAQ:TRDA) stock fell 24.59% to $15.0. Entrada Therapeutics's stock is trading at a volume of 97.2K shares as of 12:30 EST. This is 146.2% of its average full-day volume over the last 100 days. The company's market cap stands at $471.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATNX ATXI AXLA BIVI MGTA RCUS REVBU SCPS SRZN TRDA VAPO VRNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist